ARK Genomic Revolution ETF vs ProShares UltraShort Bloomberg Natural Gas ETF — how do they compare? ARK Genomic Revolution ETF trades at $44.49, while ProShares UltraShort Bloomberg Natural Gas ETF trades at $28.24. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, ProShares UltraShort Bloomberg Natural Gas ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | KOLD | |
|---|---|---|
Sector | Sector/Thematic | Leveraged / Inverse |
52-Week High | $44.55 | $49.39 |
52-Week Low | $24.02 | $13.58 |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
KOLD trades at $28.035, down 2.11% today, with technical indicators showing a bullish bias despite recent weakness. The stock faces strong resistance at $29-$30 levels while finding support at $28. Natural gas market volatility continues to drive price action, with weather forecasts and LNG export flows being key near-term catalysts. Recent news highlights steady natural gas futures trading amid mixed demand signals.
The outlook remains tactical given KOLD's leveraged exposure to natural gas price movements. Upside potential exists if weather-driven demand strengthens, but risks include production increases and storage levels. Investors should monitor EIA storage reports and global LNG demand trends for directional cues in this volatile energy sector ETF.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →KOLD is an inverse leveraged ETF that seeks to provide two times (2x) the inverse daily performance of the Bloomberg Natural Gas Subindex. It is designed for investors looking to profit from falling natural gas prices.
Read more on KOLD →